22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction
04 Dec 2023 //
GLOBENEWSWIRE
22nd Century Appoints Larry Firestone as Chairman and CEO
29 Nov 2023 //
GLOBENEWSWIRE
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
27 Nov 2023 //
GLOBENEWSWIRE
22nd Century Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
08 Nov 2023 //
GLOBENEWSWIRE
22nd Century Expands Reduced Nicotine Content Tobacco IP with Technology License
07 Nov 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
22nd Century Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
26 Oct 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Reduces Debt by $8.1 Million
25 Oct 2023 //
GLOBENEWSWIRE
22nd Century Announces Pricing of $5.25 Million Public Offering
17 Oct 2023 //
GLOBENEWSWIRE
22nd Century Announces Proposed Public Offering
16 Oct 2023 //
GLOBENEWSWIRE
22nd Century Adds 1,200 Drug Store Locations Selling VLN® in Five States
12 Sep 2023 //
GLOBENEWSWIRE
22nd Century Initiates Strategic Alternatives Process for Its Tobacco Assets
05 Sep 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
22nd Century to Announce Second Quarter 2023 Results on August 14, 2023
07 Aug 2023 //
GLOBENEWSWIRE
22nd Century Announces Executive Leadership Changes
24 Jul 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Regains Compliance with Nasdaq Listing Standards
20 Jul 2023 //
GLOBENEWSWIRE
22nd Century Launches Reduced Nicotine VLN® King Cigarettes in California
17 Jul 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) VLN Products Now Selling in Montana C-Stores
13 Jul 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Announces New Agreement with Hub, Inc.
12 Jul 2023 //
GLOBENEWSWIRE
22nd Century Announces $3.0 M Registered Direct Offering Priced Above Market
06 Jul 2023 //
GLOBENEWSWIRE
22nd Century Announces 1-for-15 Reverse Stock Split
03 Jul 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Announces Production of VLN® Homogenized Tobacco
23 Jun 2023 //
GLOBENEWSWIRE
22nd Century Announces $5.3 Mn Registered Direct Offering Priced Above Market
20 Jun 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Launching VLN® at #1 U.S. C-Store Chain in Texas
06 Jun 2023 //
GLOBENEWSWIRE
22nd Century Group Announces Participation in the LD Micro Invitational XIII
02 Jun 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Highlights Recent TCORS Symposium Findings
25 May 2023 //
GLOBENEWSWIRE
22nd Century Group Reports 1Q 2023 FYR, Introduces 2023 Full Year Revenue
09 May 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Announces Strategic License with Old Pal
02 May 2023 //
GLOBENEWSWIRE
22nd Century Announces Fully Integrated and Distribution Agreement with Cookies
05 Apr 2023 //
GLOBENEWSWIRE
22nd Century Reports Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
22nd CenturySecures $21 Million Debt Financing to Expand Working Capital
03 Mar 2023 //
GLOBENEWSWIRE
22nd Century to Participate in March 2023 Roth Investor Conference
02 Mar 2023 //
GLOBENEWSWIRE
22nd Century to Announce Fourth Quarter and Full Year 2022 Results
23 Feb 2023 //
GLOBENEWSWIRE
22nd Century Group (XXII) Acquires RX Pharmatech Ltd
24 Jan 2023 //
GLOBENEWSWIRE
Transo-Pharm Partners With 22nd Century For Global Cannabinoid API Distribution
23 Jan 2023 //
PRESS RELEASE
22nd Century (XXII) Announces Filing of U.S. DMF for CBD API
23 Jan 2023 //
GLOBENEWSWIRE
22nd Century Comments on the Advancement of NZ`s Reduced Nicotine Content Law
13 Dec 2022 //
FINANCE YAHOO
GVB Biopharma Opens New Distribution Facility in the Netherlands
17 Nov 2022 //
CONTRACTPHARMA
22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility
16 Nov 2022 //
GLOBENEWSWIRE
22nd Century Group GVB Biopharma to Exhibit at MJBizCon in Las Vegas
15 Nov 2022 //
GLOBENEWSWIRE
22nd Century Group GVB Biopharma to Exhibit at MJBizCon in Las Vegas
15 Nov 2022 //
GLOBENEWSWIRE
22nd Century Reports Business Highlights and Financial Results for the 3Q 2022
08 Nov 2022 //
GLOBENEWSWIRE
22nd Century Welcomes Reduced Nicotine Study
07 Nov 2022 //
TOBACCOREPORTER
New Study Again Shows 22nd Century’s Reduced Nicotine Content
07 Nov 2022 //
GLOBENEWSWIRE
22nd Century to Announce Q3 2022 Results on November 8, 2022
27 Oct 2022 //
GLOBENEWSWIRE
22nd Century Groupto Expand VLN Sales in Three Additional States
26 Oct 2022 //
GLOBENEWSWIRE
22nd Century (Nasdaq: XXII) to Present at LD Micro Conference on October 26
18 Oct 2022 //
GLOBENEWSWIRE
22nd Century Group to Participate in the Dawson James Small Cap Growth
06 Oct 2022 //
GLOBENEWSWIRE
22nd Century Group (Nasdaq: XXII) Expands VLN® Distributor
03 Oct 2022 //
GLOBENEWSWIRE
22nd Century Group (Nasdaq: XXII) Partners With Eagle Rock Distributing
20 Sep 2022 //
GLOBENEWSWIRE
22nd Century Group’s (Nasdaq: XXII) VLN® Cigarettes Reduced Nicotine Technology
13 Sep 2022 //
GLOBENEWSWIRE
22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer
03 Jun 2020 //
GLOBENEWSWIRE